Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.553 $0.775 Thursday, 9th May 2024 BLRX stock ended at $0.685. This is 3.83% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.27% from a day low at $0.647 to a day high of $0.694.
90 days $0.553 $1.44
52 weeks $0.553 $2.53

Historical BioLineRx Ltd. prices

Date Open High Low Close Volume
Mar 01, 2023 $0.590 $0.620 $0.570 $0.590 209 385
Feb 28, 2023 $0.550 $0.600 $0.550 $0.595 397 094
Feb 27, 2023 $0.571 $0.581 $0.550 $0.581 469 291
Feb 24, 2023 $0.570 $0.580 $0.550 $0.563 305 073
Feb 23, 2023 $0.590 $0.590 $0.560 $0.580 308 631
Feb 22, 2023 $0.585 $0.599 $0.582 $0.590 179 818
Feb 21, 2023 $0.596 $0.610 $0.590 $0.600 112 120
Feb 17, 2023 $0.600 $0.620 $0.595 $0.610 55 750
Feb 16, 2023 $0.610 $0.620 $0.580 $0.609 143 622
Feb 15, 2023 $0.600 $0.620 $0.585 $0.620 169 070
Feb 14, 2023 $0.600 $0.610 $0.590 $0.600 78 478
Feb 13, 2023 $0.600 $0.620 $0.585 $0.610 249 711
Feb 10, 2023 $0.610 $0.620 $0.570 $0.599 219 582
Feb 09, 2023 $0.620 $0.635 $0.580 $0.604 323 057
Feb 08, 2023 $0.620 $0.630 $0.610 $0.620 183 037
Feb 07, 2023 $0.620 $0.629 $0.605 $0.610 146 918
Feb 06, 2023 $0.613 $0.630 $0.600 $0.618 273 588
Feb 03, 2023 $0.618 $0.640 $0.600 $0.623 321 462
Feb 02, 2023 $0.630 $0.630 $0.603 $0.612 296 012
Feb 01, 2023 $0.619 $0.630 $0.601 $0.630 155 541
Jan 31, 2023 $0.617 $0.630 $0.600 $0.630 271 194
Jan 30, 2023 $0.620 $0.635 $0.610 $0.630 226 822
Jan 27, 2023 $0.650 $0.666 $0.620 $0.640 302 876
Jan 26, 2023 $0.680 $0.684 $0.640 $0.653 165 228
Jan 25, 2023 $0.675 $0.690 $0.662 $0.677 196 411
Click to get the best stock tips daily for free!

About BioLineRx Ltd.

BioLineRx Ltd. BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat... BLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT